9-128323048-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_016035.5(COQ4):c.103G>A(p.Gly35Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000513 in 1,612,030 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016035.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ4 | ENST00000300452.8 | c.103G>A | p.Gly35Ser | missense_variant | Exon 2 of 7 | 1 | NM_016035.5 | ENSP00000300452.3 | ||
COQ4 | ENST00000372875.3 | c.103G>A | p.Gly35Ser | missense_variant | Exon 2 of 4 | 2 | ENSP00000361966.3 | |||
COQ4 | ENST00000608951.5 | c.103G>A | p.Gly35Ser | missense_variant | Exon 2 of 3 | 2 | ENSP00000476323.1 | |||
COQ4 | ENST00000609948.1 | c.103G>A | p.Gly35Ser | missense_variant | Exon 2 of 2 | 2 | ENSP00000477292.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000192 AC: 46AN: 240110Hom.: 0 AF XY: 0.000236 AC XY: 31AN XY: 131476
GnomAD4 exome AF: 0.000546 AC: 797AN: 1459802Hom.: 2 Cov.: 31 AF XY: 0.000509 AC XY: 370AN XY: 726250
GnomAD4 genome AF: 0.000197 AC: 30AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74370
ClinVar
Submissions by phenotype
not provided Uncertain:3
BP4 -
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 35 of the COQ4 protein (p.Gly35Ser). This variant is present in population databases (rs141078819, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with COQ4-related conditions. ClinVar contains an entry for this variant (Variation ID: 580739). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.103G>A (p.G35S) alteration is located in exon 2 (coding exon 2) of the COQ4 gene. This alteration results from a G to A substitution at nucleotide position 103, causing the glycine (G) at amino acid position 35 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at